Help eliminate infectious diseases worldwide through fundamental and translational research.
PHRI seeks to continue as a global leader in infectious disease by recruiting top scientists and by combining world-class federally funded research with strategic private partnerships.
PHRI was established in New York City seven decades ago as a freestanding research institute that emphasized the application of basic science knowledge to address major health issues.
In 1942, Fiorello LaGuardia, Mayor of New York City, established the Public Health Research Institute with Dr. Ralph Muckenfuss, director of the Bureau of Laboratories, as the first director of the Public Health Research Institute. It was a unique structure, being the only basic medical research organization at the time receiving municipal support.
Through the decades, PHRI scientists have made seminal discoveries in the fields of biochemistry, genetics, microbiology, virology, immunology, cancer research, neurobiology, and infectious diseases. These researchers, many of whom are household names in science and medicine, forged a culture of discovery that earned them numerous awards including membership in the National Academy of Sciences (Sarah Ratner, Richard Novick) and a Nobel prize (Eric Kandel) while at PHRI or after their departure to other institutions.
In March 2002, PHRI moved from New York City to its current home at the International Center for Public Health (ICPH), a specialized facility for infectious disease research on the Newark campus of New Jersey Medical School (NJMS).
In December 2006, PHRI joined the University of Medicine and Dentistry of NJ and formally established as a strategic research Center within NJMS.
In July 2013, PHRI, as a component of UMDNJ, was transferred to Rutgers, The State University of New Jersey, as a result of the New Jersey Medical and Health Sciences Education Restructuring Act approved by the state legislature and signed by Governor Chris Christie on Aug. 22, 2012.